methamphetamine has been researched along with n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baron, S; Ding, Z; Raffa, RB; Rawls, SM; Roth, C; Zaveri, N | 1 |
1 other study(ies) available for methamphetamine and n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide
Article | Year |
---|---|
Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.
Topics: Aminoquinolines; Animals; Benzamides; Central Nervous System Stimulants; In Vitro Techniques; Methamphetamine; Motor Activity; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Opioid Peptides; Planarians; Receptors, Opioid; Substance Withdrawal Syndrome | 2008 |